Investment Themes
As such, a diffusion of this model to other Western economies would necessarily be accompanied by an exponential growth of the cannabis industry, which is still in its infancy, offering many investment opportunities with it. Real sectors are being set up, economic models are emerging, all under the watchful eye of giants in the agri-food and pharmaceutical industries. It is within this framework that a real asset class is emerging, with its own standards in terms of volatility and growth. The cannabis industry is indeed one of the sectors with the highest growth rates but still remains composed of non-profit actors. Market expectations are thus high and delays in achieving the objectives communicated are severely sanctioned, the price to pay to support confusing growth rates. This thematic list targets producers who play an important role in the research, production, processing and sale of cannabis for medical and recreational use.
Our selection
| Healthcare | Other Pharmaceuticals | 62Cr | -44.41% | ||
| Healthcare | Recreational Pharmaceuticals | 222.45Cr | +35.52% | ||
| Real Estate | Industrial REITs | 173.63Cr | +22.80% | ||
| Healthcare | Alternative Medicine | 104.98Cr | +6.67% | ||
| Healthcare | Medical Farming | 15Cr | -35.93% | ||
| Healthcare | Other Pharmaceuticals | 33Cr | -27.11% | ||
| Consumer Non-Cyclical | Cannabis Product Retailers | 187.75Cr | +7.08% | ||
| Real Estate | Mortgage REITs | 8.14Cr | +19.65% | ||
| Healthcare | Other Pharmaceuticals | 75.04L | -48.74% | ||
| Healthcare | Alternative Medicine | 40Cr | -8.33% | ||
| Consumer Cyclical | Nursery & Garden Centers | 9.55Cr | +0.67% | ||
| Consumer Non-Cyclical | Cannabis Product Retailers | 23Cr | -1.01% | ||
| - | - | 285.1Cr | - | ||
| Healthcare | Alternative Medicine | 20Cr | -20.45% | ||
| Consumer Non-Cyclical | Tobacco Stores | 4.71Cr | -33.93% | ||
| Healthcare | Other Pharmaceuticals | 38Cr | -12.65% | ||
| Healthcare | Other Biotechnology & Medical Research | 12Cr | +13.74% | ||
| Healthcare | Bio Therapeutic Drugs | 14Cr | -5.41% | ||
| - | - | 95.3L | - | ||
| Healthcare | Recreational Pharmaceuticals | 2.28Cr | +7.69% | ||
| Healthcare | Alternative Medicine | 6.45Cr | +5.05% | ||
| Healthcare | Alternative Medicine | 15Cr | +6.90% | ||
| Healthcare | Other Biotechnology & Medical Research | 2.82Cr | -0.14% | ||
| Healthcare | Medical Farming | 2.5Cr | 0.00% | ||
| Technology | Blockchain & Cryptocurrency (NEC) | 2.98Cr | -7.02% | ||
| Healthcare | Alternative Medicine | 35Cr | - | ||
| Technology | Other IT Services & Consulting | 1.15Cr | -25.72% | ||
| Healthcare | Recreational Pharmaceuticals | 60Cr | -27.71% | ||
| Industrials | Other Industrial Machinery & Equipment | 1.96Cr | -39.74% | ||
| Consumer Non-Cyclical | Other Personal Products | 6.26Cr | -48.81% | ||
| Healthcare | Bio Therapeutic Drugs | 2.45Cr | -46.67% | ||
| - | - | 4 | - | ||
| - | - | 54.18L | - | ||
News of the components
| ░░░░ | ░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░ ░░░░░ ░░░░░░░░░░ | ░░ |
| ░░░░ | ░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░░ ░░░░░░ ░░░░░ ░░░ ░░░░░░ | ░░ |
| ░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░ ░░ ░░░░░░░░░ | ░░ |
| ░░░░ | ░░░░░░ ░░░░ ░░░ ░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░ ░░░░░ ░░░░░░ ░░░ ░░░░░░ | ░░ |
| ░░░░ | ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░ ░░ ░░░░░░ ░░░░░░░ ░░░░░░░░░ | ░░ |
| ░░░░ | ░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░ ░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░░░ | ░░ |
| ░░░░ | ░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░░░░░ ░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░ | ░░ |
| ░░░░ | ░░░░░░ ░░░░░░ ░░░░ ░░░░░░░░ ░░░ ░░ ░░░ ░░░ ░░░░░░░░░ | ░░ |
| ░░░░ | ░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ ░░ ░░░░░░ ░░░░░░░ ░░░░░░░░░░░░ ░░░░░░ ░░░░░ ░░░░░░░░░░ | ░░ |
| ░░░░ | ░ ░░░░░░░░░░ ░░░░░ ░ ░░░░░░░░░░░░░░░░░░░ ░░░░░░ | ░░ |
| ░░░░ | ░░░░░░░░░ ░░░░░░░░ ░░░░░ ░░░░░░░░░░ ░ ░░░░░░░ ░░░░░░░ | ░░ |
| ░░░░ | ░░░░░░░░░ ░░░░░░░░ ░░░░░ ░░░░░░░░░ ░░ ░░░░░░ ░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░ ░░ ░░░ ░░░ ░░░░░░░░░░ | ░░ |
| ░░░░ | ░░░░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░ ░░░ ░░░░░░ ░░░░░ ░░░░░░ ░░ ░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░ ░░░ ░░░░ ░░░░░░░░░░░ | ░░ |
| ░░░░ | ░░░░░░░░░ ░░░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░░░ | ░░ |
| ░░░░ | ░░░░ ░░░░░░░ ░░░░ ░░░░░░ ░░░░ ░░░░░░░░░ ░░ ░░░░░░ ░░░░░░ ░░░░ ░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░ ░░░░ ░░░░░ | ░░ |
| ░░░░ | ░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░ |
| ░░░░ | ░░░░░░░ ░░░░░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░ ░░░ ░░░░░░░░ ░░░░░░ ░░░░ | ░░ |
| ░░░░ | ░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░ | ░░ |
| ░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░ ░░ ░░░░ ░░░░ ░░ ░░░░░░░░ | ░░ |
Heatmap
Sector allocation
Ratings chart - Surperformance
Ratings ESG MSCI
- Stock Market
- Investment Themes
- The Cannabis Industry, the emergence of a new asset class
















